Search

We collectively don’t know much about how phages work in cocktails, or how best to optimize phage therapy when multiple phages are combined. Rosanna Wright (University of York) and colleagues have shown, using P. aeruginosa and pairs of pha

You may have heard of the Nagoya Protocol in the context of isolating or sharing phages or bacteria. But what is the Nagoya Protocol, and how does it apply to phage research and development? This week, we've put together a primer to help ex

The Center for Innovative Phage Applications and Therapeutics (IPATH) at UCSD has published the first issue of its new quarterly newsletter. This quarter's issue features an interview with Dr. Hedieh Attai, a postdoc at IPATH, along with in

Here's a new phage therapy podcast episode featuring Dr. Aleksandra Petrovic-Fabijan and Dr. Ruby Lin from the Westmead Institute for Medical Research in Westmead, Australia. [Medical Journal of Australia Podcast, 21 mins]

Related to the new NIAID request for applications (RFA) for phage studies, here's a videocast of the NIAID council meeting where they discuss their phage interests and why they're going to fund phage studies now and in the future. Start wat

Kevin Yehl of MIT and colleagues have developed a high-throughput strategy to genetically engineer host range-determining regions within phage tail fiber proteins to create libraries of millions of phages with different receptor binding cap

Sara Clifton of the University of Illinois at Urbana-Champaign and colleagues have used population modeling to examine the role of latent prophages in bacterial populations in response to antibiotic treatment. They show that antibiotics can

Michele Mutti and Lorenzo Corsini of the phage biotech company PhagoMed have published a review on GMP production of phages for therapy. They review the literature covering technical issues and approaches to increase robustness at each step

The Center for Innovative Phage Applications and Therapeutics (IPATH) at UCSD has published the first issue of its new quarterly newsletter. This quarter's issue features an interview with Dr. Hedieh Attai, a postdoc at IPATH, along with in

Here's a new phage therapy podcast episode featuring Dr. Aleksandra Petrovic-Fabijan and Dr. Ruby Lin from the Westmead Institute for Medical Research in Westmead, Australia. [Medical Journal of Australia Podcast, 21 mins]

Dr. Soleimani I am seeking a research position in phage therapy or molecular phage studies. I hold a Ph.D from Shahid Beheshti University, Tehran, Iran (Department of microbiology and microbial biotechnology, faculty of life sciences and bi

Dr. Soleimani I am seeking a research position in phage therapy or molecular phage studies. I hold a Ph.D from Shahid Beheshti University, Tehran, Iran (Department of microbiology and microbial biotechnology, faculty of life sciences and bi

Michele Mutti and Lorenzo Corsini of the phage biotech company PhagoMed have published a review on GMP production of phages for therapy. They review the literature covering technical issues and approaches to increase robustness at each step

PHAGES.fr The annual meeting of the Phages.fr (French Phage network) Grenoble, France

The PhageBio group, Lone Brøndsted We are looking for a highly motivated and dynamic researcher for a 2-years post doc position in Bacteriophage biology and application starting on January 1st 2020 or as soon as possible hereafter. The post

CyVerse provides life scientists with powerful computational infrastructure to handle huge datasets and complex analyses, thus enabling data-driven discovery. CyVerse provides life scientists with powerful computational infrastructure to ha

The PhageBio group, Lone Brøndsted We are looking for a highly motivated and dynamic researcher for a 2-years post doc position in Bacteriophage biology and application starting on January 1st 2020 or as soon as possible hereafter. The post

Sara Clifton of the University of Illinois at Urbana-Champaign and colleagues have used population modeling to examine the role of latent prophages in bacterial populations in response to antibiotic treatment. They show that antibiotics can

Related to the new NIAID request for applications (RFA) for phage studies, here's a videocast of the NIAID council meeting where they discuss their phage interests and why they're going to fund phage studies now and in the future. Start wat

Kevin Yehl of MIT and colleagues have developed a high-throughput strategy to genetically engineer host range-determining regions within phage tail fiber proteins to create libraries of millions of phages with different receptor binding cap